Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling
Authors
Keywords
-
Journal
Nature Communications
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-11-21
DOI
10.1038/s41467-017-02002-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phosphoproteomic comparison of Pik3ca and Pten signalling identifies the nucleotidase NT5C as a novel AKT substrate
- (2017) Larissa S. Moniz et al. Scientific Reports
- Targeting PI3K in Cancer: Impact on Tumor Cells, Their Protective Stroma, Angiogenesis, and Immunotherapy
- (2016) K. Okkenhaug et al. Cancer Discovery
- Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival
- (2016) Luc G.T. Morris et al. Oncotarget
- Heterozygous expression of the oncogenic Pik3caH1047R mutation during murine development results in fatal embryonic and extraembryonic defects
- (2015) Lauren M. Hare et al. DEVELOPMENTAL BIOLOGY
- Molecules in medicine mini-review: isoforms of PI3K in biology and disease
- (2015) Bart Vanhaesebroeck et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity
- (2015) Alexandra Van Keymeulen et al. NATURE
- Transient PLK4 overexpression accelerates tumorigenesis in p53-deficient epidermis
- (2015) Özdemirhan Serçin et al. NATURE CELL BIOLOGY
- Over-expression of Plk4 induces centrosome amplification, loss of primary cilia and associated tissue hyperplasia in the mouse
- (2015) Paula A. Coelho et al. Open Biology
- Cytokinesis Failure Triggers Hippo Tumor Suppressor Pathway Activation
- (2014) Neil J. Ganem et al. CELL
- Characterization of the Novel and Specific PI3K Inhibitor NVP-BYL719 and Development of the Patient Stratification Strategy for Clinical Trials
- (2014) C. Fritsch et al. MOLECULAR CANCER THERAPEUTICS
- PI3K and cancer: lessons, challenges and opportunities
- (2014) David A. Fruman et al. NATURE REVIEWS DRUG DISCOVERY
- Causes and consequences of centrosome abnormalities in cancer
- (2014) S. A. Godinho et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Tolerance of Whole-Genome Doubling Propagates Chromosomal Instability and Accelerates Cancer Genome Evolution
- (2014) S. M. Dewhurst et al. Cancer Discovery
- Physiological expression of the PI3K-activating mutationPik3caH1047Rcombines withApcloss to promote development of invasive intestinal adenocarcinomas in mice
- (2013) Lauren M. Hare et al. BIOCHEMICAL JOURNAL
- Mouse models ofPIK3CAmutations: one mutation initiates heterogeneous mammary tumors
- (2013) Shany Koren et al. FEBS Journal
- Pan-cancer patterns of somatic copy number alteration
- (2013) Travis I Zack et al. NATURE GENETICS
- Centrosomes, chromosome instability (CIN) and aneuploidy
- (2012) Benjamin D Vitre et al. CURRENT OPINION IN CELL BIOLOGY
- An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice
- (2012) Kathryn M. Kinross et al. JOURNAL OF CLINICAL INVESTIGATION
- Absolute quantification of somatic DNA alterations in human cancer
- (2012) Scott L Carter et al. NATURE BIOTECHNOLOGY
- Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA
- (2012) Marjorie J Lindhurst et al. NATURE GENETICS
- Conditional activation of Pik3ca H1047R in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutations
- (2012) W Yuan et al. ONCOGENE
- Physiological Levels of Pik3caH1047R Mutation in the Mouse Mammary Gland Results in Ductal Hyperplasia and Formation of ERα-Positive Tumors
- (2012) Anjali Tikoo et al. PLoS One
- Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110 (PIK3CA)
- (2012) J. E. Burke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Causes and Consequences of Polyploidy in Normal Development and Cancer
- (2011) Teresa Davoli et al. Annual Review of Cell and Developmental Biology
- Both p110α and p110β isoforms of PI3K can modulate the impact of loss-of-function of the PTEN tumour suppressor
- (2011) Inma M. Berenjeno et al. BIOCHEMICAL JOURNAL
- Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation
- (2011) J. R. Adams et al. CANCER RESEARCH
- p53: Guardian of ploidy
- (2011) Yael Aylon et al. Molecular Oncology
- Activated ROCK II by-passes the requirement of the CDK2 activity for centrosome duplication and amplification
- (2011) K Hanashiro et al. ONCOGENE
- The PI3K–Akt mediates oncogenic Met-induced centrosome amplification and chromosome instability
- (2010) Hyun-Ja Nam et al. CARCINOGENESIS
- Proliferation of aneuploid human cells is limited by a p53-dependent mechanism
- (2010) Sarah L. Thompson et al. JOURNAL OF CELL BIOLOGY
- A potential role for NEDD1 and the centrosome in senescence of mouse embryonic fibroblasts
- (2010) J A Manning et al. Cell Death & Disease
- A mechanism linking extra centrosomes to chromosomal instability
- (2009) Neil J. Ganem et al. NATURE
- Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes
- (2008) M. Kwon et al. GENES & DEVELOPMENT
- Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
- (2008) Jeffrey A Engelman et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started